BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12928962)

  • 1. Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis.
    Schmid DT; Kneifel S; Stoeckli SJ; Padberg BC; Merrill G; Goerres GW
    Eur Radiol; 2003 Sep; 13(9):2119-21. PubMed ID: 12928962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
    Mikosch P; Würtz FG; Gallowitsch HJ; Kresnik E; Lind P
    Wien Med Wochenschr; 2003; 153(3-4):89-92. PubMed ID: 12658970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
    Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
    Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of thyroid lymphoma and follow-up evaluation using Ga-67 scintigraphy.
    Nishiyama Y; Yamamoto Y; Yokoe K; Satoh K; Ohkawa M
    Ann Nucl Med; 2003 Jul; 17(5):351-7. PubMed ID: 12971631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
    Wolf G; Aigner RM; Schaffler G; Schwarz T; Krippl P
    Nucl Med Commun; 2003 Dec; 24(12):1225-30. PubMed ID: 14627848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body (18)F-FDG PET/CT in primary non-Hodgkin's lymphoma of the thyroid associated with Hashimoto's thyroiditis and bilateral kidney infiltration.
    Roldán-Valadez E; Ortega-López N; Cervera-Ceballos E; Valdivieso-Cárdenas G; Vega-González I; Granados-García M
    Rev Esp Med Nucl; 2008; 27(1):34-9. PubMed ID: 18208780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
    Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
    Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining when to operate on patients with Hashimoto's thyroiditis with nodular lesions: the role of ultrasound-guided fine needle aspiration cytology.
    Su DH; Liao KM; Hsiao YL; Chang TC
    Acta Cytol; 2004; 48(5):622-9. PubMed ID: 15471253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG-PET in the follow-up of thyroid cancer.
    Lind P; Kresnik E; Kumnig G; Gallowitsch HJ; Igerc I; Matschnig S; Gomez I
    Acta Med Austriaca; 2003; 30(1):17-21. PubMed ID: 12558561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hashimoto's thyroiditis and thyroid cancer.
    Noureldine SI; Tufano RP
    Curr Opin Oncol; 2015 Jan; 27(1):21-5. PubMed ID: 25390557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Focal to Diffuse Thyroid Uptake Detected by 18F-FDG PET/CT: Malignant Metastatic Disease or Benign Thyroiditis?
    Thuillier P; Crouzeix G; Descourt R; Salaun PY; Abgral R
    Clin Nucl Med; 2018 Sep; 43(9):e310-e311. PubMed ID: 29939952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical intervention in chronic (Hashimoto's) thyroiditis.
    Thomas CG; Rutledge RG
    Ann Surg; 1981 Jun; 193(6):769-76. PubMed ID: 6894684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphic varieties in Hashimoto's thyroiditis and comparison with ultrasonography.
    Yarman S; Mudun A; Alagol F; Tanakol R; Azizlerli H; Oguz H; Cantez S
    Nucl Med Commun; 1997 Oct; 18(10):951-6. PubMed ID: 9392797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
    Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
    Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
    Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
    Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
    Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huge thyroid uptake of 18F-FDG in a patient with Hashimoto's thyroiditis referred for a malignant thyroid lesion.
    Yoshihara A; Isozaki O; Okubo Y; Maki M; Kusakabe K; Takano K
    Thyroid; 2008 May; 18(5):579-80. PubMed ID: 18407754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.